Table 1 Basic characteristics of all the patients
Characteristic | All patients (n = 800) | DM2 patients (n = 400) | Non-DM patients (n = 400) |
|---|---|---|---|
Age (years) | 56.7 ± 12.1 | 55.4 ± 13.5 | 56.3 ± 10.8 |
Male (%) | 411 (51.37) | 216 (54.00) | 195 (48.75) |
BMI (kg/m2) | 22.27 ± 2.41 | 22.43 ± 2.16 | 21.85 ± 2.32 |
Mean heart rate | 62.7 ± 11.4 | 64.3 ± 12.5 | 61.8 ± 13.1 |
Hypertension (%) | 510 (63.75) | 297 (74.25) | 213 (53.25) |
Current smoking (%) | 343 (42.88) | 145 (36.25) | 198 (49.50) |
Family history of coronary disease (%) | 484 (60.50) | 263 (65.75) | 221 (55.25) |
CIMT (mm) | 0.83 ± 0.22 | 0.96 ± 0.31 | 0.78 ± 0.15 |
TC (mmol/L) | 4.77 ± 1.14 | 4.70 ± 1.12 | 4.85 ± 1.13 |
TG (mmol/L) | 2.15 ± 1.78 | 2.41 ± 2.03 | 1.88 ± 1.45 |
HDL-C (mmol/L) | 1.27 ± 0.31 | 1.22 ± 0.30 | 1.33 ± 0.31 |
LDL-C (mmol/L) | 2.73 ± 0.88 | 2.65 ± 0.84 | 2.82 ± 0.90 |
hs-CRP (mmol/L) | 1.45 (0.65–3.405) | 1.785 (0.88–4.71) | 1.08 (0.53–2.7) |
Medication use | |||
Oral hypoglecemic agents(%) | 421 (52.63) | 268 (67.00) | 153 (38.25) |
Aspirin(%) | 324 (40.50) | 209 (52.25) | 115 (28.75) |
Beta-blocker (%) | 139 (17.38) | 72 (18.00) | 67 (16.75) |
ACE inhibitor or ARB(%) | 157 (19.63) | 83 (20.75) | 74 (18.50) |
Calcium channel blockers(%) | 143 (17.88) | 74 (18.50) | 69 (17.25) |